Improved chemokine homing enhances CAR T–cell therapy for osteosarcoma
Chimeric antigen receptor (CAR) T–cell immunotherapy re-engineers a patient’s immune cells to target cancer cells.…
Author ONA Editor
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
FDA approves blood test as a primary screening option for colorectal cancer
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, has announced that the U.S.…
Gestational diabetes does not increase risk of breast cancer, large Danish study finds
Women who develop gestational diabetes are not more likely to go on to be diagnosed…
Radiotherapy benefits last a decade, breast cancer study reveals
Providing radiotherapy after surgery could prevent breast cancer from returning in the same place for…
FDA approves vorasidenib
A new drug for treatment of a type of brain cancer, called IDH-mutant low-grade glioma,…
Link discovered between sensory neurones and breast cancer metastasis
Cancer doesn’t grow in a vacuum – each tumour grows in a particular microenvironment within…
New evidence casts doubt on a much-hyped blood test for early cancer detection
New evidence published by The BMJ casts doubt on a much-hyped blood test for the NHS that…
How does an effective cancer therapy damage the heart?
Cytotoxic T-lymphocyte antigen 4 (CTLA-4) is a protein receptor on T immune cells that prevents…
Fibroblast functionality: a pivotal piece in cancer’s spreading puzzle
A new study reviews how cancer-associated fibroblasts (CAFs) influence lymph node metastasis. Researchers identified various…
Deciphering inflammation-induced tumourigenesis: unveiling gastric cancer’s trail with network and AI
In a pioneering venture, researchers have harnessed AI and multi-omics to shed light on the…